Form 4: AEON Biopharma CEO Buys Shares
Insider Transaction (Form 4)
Robert E. Bancroft, President and CEO and a Director of AEON Biopharma, Inc., purchased 152,333 shares of common stock on November 19, 2026 for $0.13 per share.
Summary
- Open-market purchase: acquired 152,333 Class A Common Stock at $0.13 ($19,590) on November 19, 2026; holds 3,329,436 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $19,590, committing personal capital to the stock.
Insider Transactions
Robert E. Bancroft — Director, Officer (President and CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-11-19 | Open-market purchase | Class A Common Stock | 152,333 | $0 | $19.6K | 3,329,436 |
Key Dates
| Date | Description |
|---|---|
| 2026-11-19 | Open-market purchase (152,333 shares) |
Keywords
insider transaction, Form 4, AEON, AEON Biopharma, Inc., bullish, Robert E. Bancroft
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.